Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.54 |
| ▸ | SLC1A1 | P43005 | 9/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 8/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 7/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 6/20 | 0.45 |
| ▸ | GRIK2 | Q13002 | 5/20 | 0.45 |
| ▸ | GGT1 | P19440 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25564416 | 0.82 | SLC7A5 (0.43) | SLC7A5SLC1A1SLC1A2SLC1A3 | |
| SCHEMBL3187052 | 0.79 | SLC7A5 (0.56) | SLC7A5SLC1A1SLC1A2SLC1A3GRIK1 | |
| SCHEMBL25660521 | 0.77 | SLC7A5 (0.60) | SLC7A5SLC1A1SLC1A2SLC1A3GRIK1 | |
| Leucine SCHEMBL6450505 | 0.77 | SLC7A5 (0.82) | SLC7A5SLC1A1SLC1A2SLC1A3GRIK1 | |
| SCHEMBL16584647 | 0.77 | SLC7A5 (0.60) | SLC7A5SLC1A1SLC1A2SLC1A3GRIK1 | |
| Hydrochloric Acid SCHEMBL8892666 | 0.77 | SLC7A5 (0.65) | SLC7A5SLC1A1SLC1A2SLC1A3GRIK1 | |
| SCHEMBL4961345 | 0.77 | SLC7A5 (0.48) | SLC7A5SLC1A1SLC1A2SLC1A3GRIK1 | |
| SCHEMBL13461523 | 0.76 | LAP3 (0.48) | SLC7A5SLC1A2SLC1A3 | |
| SCHEMBL14445462 | 0.76 | SLC1A3 (0.34) | SLC7A5SLC1A1SLC1A2SLC1A3 | |
| SCHEMBL8072286 | 0.76 | LAP3 (0.48) | SLC7A5SLC1A2SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2143728-A1 | Improved process for the preparation of copolymer-1 | Momenta Pharmaceuticals, Inc. (US) | 2010-01-13 | — | — | EP | disclosed |
| EP-2046817-B1 | IMPROVED PROCESS FOR THE PREPARATION OF COPOLYMER-1 | MOMENTA PHARMACEUTICALS INC (US) | 2009-12-16 | — | — | EP | disclosed |
| EP-2046817-A1 | IMPROVED PROCESS FOR THE PREPARATION OF COPOLYMER-1 | Momenta Pharmaceuticals, Inc. (US) | 2009-04-15 | — | — | EP | disclosed |
| US-20080021192-A1 | PROCESS FOR THE PREPARATION OF COPOLYMER-1 | MOMENTA PHARMACEUTICALS, INC. (US) | 2008-01-24 | — | — | US | disclosed |
| WO-2008006026-A1 | IMPROVED PROCESS FOR THE PREPARATION OF COPOLYMER-1 | MOMENTA PHARMACEUTICALS, INC. (US) | 2008-01-10 | — | — | WO | disclosed |
| CN-1052144-A | The Compounds and methods for of diagnosis and treatment cancer | AUSTRALIAN COMMERCIAL RESEARCH (AU) | 1991-06-12 | — | — | CN | disclosed |